atRA has also been shown to induce differentiation of the t(8;21) core binding factor (CBF) AML cell line Kasumi-1[35], although it has shown no clinical activity in CBF AML[15–18]. This evidence concerns the gene CEBPZ and acute myeloid leukemia.